Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Haire, Anna"'
Autor:
George G; Translational Oncology and Urology Research, King's College London, London, UK. Electronic address: gincy.e.george@kcl.ac.uk., Rudman S; Medical Oncology, Guy's and St Thomas' Foundation Trust, London, UK., Fleure L; Medical Oncology, Guy's and St Thomas' Foundation Trust, London, UK., Moon Z; Institute of Psychiatry, Psychology & Neuroscience, Health Psychology Section, King's College London, London, UK., Garmo H; Translational Oncology and Urology Research, King's College London, London, UK., Cahill F; Translational Oncology and Urology Research, King's College London, London, UK., Fox L; Translational Oncology and Urology Research, King's College London, London, UK., Moss C; Translational Oncology and Urology Research, King's College London, London, UK., Wylie H; Translational Oncology and Urology Research, King's College London, London, UK., Haire A; Translational Oncology and Urology Research, King's College London, London, UK., Van Hemelrijck M; Translational Oncology and Urology Research, King's College London, London, UK.
Publikováno v:
Seminars in oncology nursing [Semin Oncol Nurs] 2022 Aug; Vol. 38 (4), pp. 151236. Date of Electronic Publication: 2021 Dec 14.
Autor:
Manuelli V; School of Cancer and Pharmaceutical Sciences, Kings College London, Rm.2.34A New Hunts House, London, SE1 1UL, UK., Cahill F; Department of Translational Oncology and Urology Research, Faculty of Life Sciences and Medicine, King's College London, London, UK., Wylie H; Department of Translational Oncology and Urology Research, Faculty of Life Sciences and Medicine, King's College London, London, UK., Gillett C; School of Cancer and Pharmaceutical Sciences, Kings College London, Rm.2.34A New Hunts House, London, SE1 1UL, UK., Correa I; NIHR Biomedical Research Centre at Guy's and St. Thomas's Hospitals, King's College London, London, UK., Heck S; Institute of Diabetes Research, Helmholtz Zentrum Munchen, Munich, Germany., Rimmer A; School of Cancer and Pharmaceutical Sciences, Kings College London, Rm.2.34A New Hunts House, London, SE1 1UL, UK., Haire A; Department of Translational Oncology and Urology Research, Faculty of Life Sciences and Medicine, King's College London, London, UK., Van Hemelrijck M; School of Cancer and Pharmaceutical Sciences, Kings College London, Rm.2.34A New Hunts House, London, SE1 1UL, UK.; Department of Translational Oncology and Urology Research, Faculty of Life Sciences and Medicine, King's College London, London, UK., Rudman S; Department of Translational Oncology and Urology Research, Faculty of Life Sciences and Medicine, King's College London, London, UK.; Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Wells CM; School of Cancer and Pharmaceutical Sciences, Kings College London, Rm.2.34A New Hunts House, London, SE1 1UL, UK. claire.wells@kcl.ac.uk.
Publikováno v:
BMC cancer [BMC Cancer] 2022 Apr 09; Vol. 22 (1), pp. 386. Date of Electronic Publication: 2022 Apr 09.
Autor:
Beyer K; Translational and Oncology Research (TOUR), King's College London, Faculty of Life Sciences and Medicine, London, UK katharina.beyer@kcl.ac.uk., Moris L; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Lardas M; Department of Urology, Metropolitan Hospital, Athens, Greece., Haire A; Translational and Oncology Research (TOUR), King's College London, Faculty of Life Sciences and Medicine, London, UK., Barletta F; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy., Scuderi S; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy., Molnar M; Bayer AG, Berlin, Germany., Herrera R; Bayer AG, Berlin, Germany., Rauf A; Department of Urology, Mid Cheshire Hospitals, NHS Foundation Trust, Crewe, UK., Campi R; Department of Minimally Invasive and Robotic Urologic Surgery and Kidney Transplantation, University of Florence, Florence, Italy., Greco I; Department of Minimally Invasive and Robotic Urologic Surgery and Kidney Transplantation, University of Florence, Florence, Italy., Shiranov K; CDC Zdorovie, Rostov-on-Don, Russia., Dabestani S; Dept. of Translational Medicine, Division of Urological Cancers, Lund University, Kristianstad Central Hospital, Malmo, Sweden., van den Broeck T; Department of Urology, University Hospitals Leuven, Leuven, Belgium., Arun S; Flatiron Health, London, UK., Gacci M; Department of Minimally Invasive and Robotic Urologic Surgery and Kidney Transplantation, University of Florence, Florence, Italy., Gandaglia G; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy., Omar MI; Academic Urology Unit, University of Aberdeen, Aberdeen, UK., MacLennan S; Academic Urology Unit, University of Aberdeen, Aberdeen, UK., Roobol MJ; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands., Farahmand B; Global Epidemiology, Bayer AG, Stockholm, Sweden., Vradi E; Bayer AG, Berlin, Germany., Devecseri Z; Sanofi, Paris, France., Asiimwe A; Bayer AG, Berlin, Germany., Zong J; Global Medical Affairs Oncology, Real World Evidence, Bayer HealthCare Pharmaceuticals Inc, Whippany, New Jersey, USA., Maclennan SJ; Academic Urology Unit, University of Aberdeen, Aberdeen, UK., Collette L; EORTC Headquarters, Brussels, Belgium., NDow J; Department of Urology, Erasmus University Medical Center, Rotterdam, The Netherlands., Briganti A; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.; Department of Urology, University Vita e Salute-San Raffaele, Milan, Italy., Bjartell A; Department of Translational Medicine, Lund University, Malmö, Sweden., Van Hemelrijck M; Translational and Oncology Research (TOUR), King's College London, Faculty of Life Sciences and Medicine, London, UK.
Publikováno v:
BMJ open [BMJ Open] 2022 Apr 04; Vol. 12 (4), pp. e058267. Date of Electronic Publication: 2022 Apr 04.
Autor:
Marsden T; Division of Surgical and Interventional Sciences, University College London, London, UK teresa.marsden@ucl.ac.uk.; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Lomas DJ; Department of Urology, Mayo Clinic, Rochester, New York, USA., McCartan N; Division of Surgical and Interventional Sciences, University College London, London, UK.; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Hadley J; Division of Surgical and Interventional Sciences, University College London, London, UK.; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Tuck S; ReIMAGINE Consortium Patient Representative, University College London, London, UK., Brown L; MRC Clinical Trials Unit, University College London, London, UK., Haire A; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Moss CL; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Green S; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Van Hemelrijck M; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Coolen T; London Institute for Mathematical Sciences, London, UK., Santaolalla A; Cancer Epidemiology Group, Division of Cancer Studies, King's College London, London, UK., Isaac E; Centre for Medical Imaging, University College London, London, UK., Brembilla G; Centre for Medical Imaging, University College London, London, UK., Kopcke D; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Giganti F; Division of Surgical and Interventional Sciences, University College London, London, UK.; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Sidhu H; Centre for Medical Imaging, University College London, London, UK., Punwani S; Centre for Medical Imaging, University College London, London, UK., Emberton M; Division of Surgical and Interventional Sciences, University College London, London, UK.; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Moore CM; Division of Surgical and Interventional Sciences, University College London, London, UK.; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.
Publikováno v:
BMJ open [BMJ Open] 2021 Sep 30; Vol. 11 (9), pp. e048144. Date of Electronic Publication: 2021 Sep 30.
Autor:
Marsden T; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: teresa.marsden@ucl.ac.uk., McCartan N; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Hadley J; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Tuck S; ReIMAGINE Consortium Patient Representative., Brown L; MRC Clinical Trials Unit, University College London, London, UK., Haire AJ; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Moss CL; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Green S; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Van Hemelrijck M; Translational Oncology & Urology Research, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK., Coolen T; London Institute for Mathematical Sciences, London, UK., Santaolalla A; Cancer Epidemiology Group, Division of Cancer Studies, King's College London School of Medicine, London, UK., Isaac E; Centre for Medical Imaging, University College London, London, UK., Brembilla G; Centre for Medical Imaging, University College London, London, UK., Kopcke D; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Giganti F; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Radiology, University College London Hospitals NHS Foundation Trust, London, UK., Sidhu H; Centre for Medical Imaging, University College London, London, UK., Punwani S; Centre for Medical Imaging, University College London, London, UK., Emberton M; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK., Moore CM; UCL Division of Surgical & Interventional Sciences, University College London, London, UK; Department of Urology, University College London Hospitals NHS Foundation Trust, London, UK.
Publikováno v:
European urology focus [Eur Urol Focus] 2021 May; Vol. 7 (3), pp. 503-505. Date of Electronic Publication: 2021 Apr 23.
Autor:
Beyer K; Translational Oncology and Urology Research (TOUR), King's College London, London, UK katharina.beyer@kcl.ac.uk., Moris L; Department of Urology, KU Leuven University Hospitals Leuven, Leuven, Flanders, Belgium., Lardas M; Department of Urology, Metropolitan Hospital Athens, Athens, Attike, Greece., Haire A; Translational Oncology and Urology Research (TOUR), King's College London, London, UK., Barletta F; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milano, Lombardia, Italy., Scuderi S; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milano, Lombardia, Italy., Vradi E; Medical Affairs and PV, Bayer Pharma AG, Berlin, Germany., Gandaglia G; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milano, Lombardia, Italy., Omar MI; Academic Urology Unit, Health Services Research Unit, University of Aberdeen, Aberdeen, Aberdeen, UK., MacLennan S; Academic Urology Unit, Health Services Research Unit, University of Aberdeen, Aberdeen, Aberdeen, UK., Zong J; Epidemiology, Bayer U.S, Whippany, New Jersey, USA., Farahmand B; Global Epidemiology, Bayer AG, Stockholm, Sweden., Maclennan SJ; Academic Urology Unit, Health Services Research Unit, University of Aberdeen, Aberdeen, Aberdeen, UK., Devecseri Z; Sanofi SA, Paris, Île-de-France, France., Asiimwe A; Medical Affairs and PV, Bayer Pharma AG, Berlin, Germany., Collette L; EORTC, Brussels, Belgium., Bjartell A; Skåne University Hospital, Malmö, Sweden., Ndow J; Guidelines Office, European Association of Urology, Arnhem, Netherlands., Briganti A; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milano, Lombardia, Italy.; Department of Urology and Division of Experimental Oncology, Urological Research Institute, Vita-Salute University San Raffaele, RCCS San Raffaele Scientific Institute, Milan, Italy., Van Hemelrijck M; Translational Oncology and Urology Research (TOUR), King's College London, London, UK.
Publikováno v:
BMJ open [BMJ Open] 2021 Feb 11; Vol. 11 (2), pp. e040531. Date of Electronic Publication: 2021 Feb 11.